Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Honeybee Propolis Extract Impedes Prostate Cancer Cell Growth

By LabMedica International staff writers
Posted on 14 May 2012
Cancer researchers have discovered the molecular mechanism that utilizes the honeybee propolis component caffeic acid phenethyl ester (CAPE) to arrest the growth of prostate cancer cells in culture and in mouse xenografts.

CAPE is a bioactive component derived from honeybee hive propolis. More...
It has been shown to have antimitogenic, anticarcinogenic, and other beneficial medicinal properties. Many of its effects have been shown to be mediated through its inhibition of NF-kappaB signaling pathways. Notably, CAPE down-regulates the mdr-1 gene, considered responsible for the resistance of cancer cells to chemotherapeutic agents.

In the current study investigator at the University of Chicago (IL, USA) employed a systematic approach to uncover the long- and short- term effects of CAPE on the signaling networks in human prostate cancer cells.

They reported in the May 1, 2012, issue of the journal Cancer Prevention Research that dosages of CAPE dependently suppressed the proliferation in culture of the LNCaP, DU-145, and PC-3 lines of human prostate cancer cells. Furthermore, administration of CAPE significantly inhibited growth of LNCaP tumor xenografts in nude mice.

Working with LNCaP cells as a model system, the investigators examined the effect of CAPE on gene expression, protein signaling, and transcriptional regulatory networks using a novel series of micro-Western and PCR arrays. They found that CAPE acted through inhibition of Akt-related protein signaling networks. Akt, also known as protein kinase B (PKB), is a serine/threonine-specific protein kinase that plays a key role in multiple cellular processes such as glucose metabolism, apoptosis, cell proliferation, transcription, and cell migration. Overexpression of Akt-1 or c-Myc (v-myc myelocytomatosis viral oncogene homolog), a downstream target of Akt signaling, significantly blocked the antiproliferative effects of CAPE.

“If you feed CAPE to mice daily, their tumors will stop growing. After several weeks, if you stop the treatment, the tumors will begin to grow again at their original pace,” said senior author Dr. Richard B. Jones, assistant professor of genomics and systems biology at the University of Chicago. “So it does not kill the cancer, but it basically will indefinitely stop prostate cancer proliferation.”

“It appears that CAPE basically stops the ability of prostate cancer cells to sense that there is nutrition available. They stop all of the molecular signatures that would suggest that nutrition exists, and the cells no longer have that proliferative response to nutrition,” said Dr. Jones. “A typical problem in bringing some of these herbal remedies into the clinic is that nobody knows how they act, nobody knows the mechanism, and therefore researchers are typically very hesitant to add them to any pharmaceutical treatment strategy. Now we will actually be able to systematically demonstrate the parts of cell physiology that are affected by these compounds.”

Related Links:

University of Chicago



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Clinical Chemistry System
P780
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.